InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Kennedy Giulia C, Directeur Scientifique et Médical. Director active across 1 company, notably Veracyte, INC.. Aggregated, 18 filings have been recorded. Split: 0 buy · 2 sells. Total volume traded: €53k. Activity tracked since 2 June 2021. The latest transaction was disclosed on 6 December 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kennedy Giulia C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
1,023 shares@ US$27.032.9% of flowCommon StockSEC:0001384101-22-000157:0
1,008 shares@ US$29.143.1% of flowCommon StockSEC:0001384101-22-000155:0
2 shares@ US$14.340.0% of flowCommon StockSEC:0001384101-22-000145:0
1,023 shares@ US$25.002.9% of flowCommon StockSEC:0001384101-22-000141:0
1,008 shares@ US$19.182.2% of flowCommon StockSEC:0001384101-22-000131:0
10,702 shares0Common StockSEC:0001384101-22-000113:0
1,008 shares@ US$18.230.0006% mcap2.1% of flowCommon StockSEC:0001384101-22-000074:0
42,412 shares0Common StockSEC:0001384101-22-000054:0
42,412 shares0Common StockSEC:0001384101-22-000046:0
10,337 shares@ US$27.8440.4% of flowCommon StockSEC:0001384101-22-000040:0
4,406 shares@ US$5.983.6% of flowCommon StockSEC:0001384101-21-000180:0
912 shares@ US$39.224.9% of flowCommon StockSEC:0001384101-21-000176:0
149 shares@ US$51.801.0% of flowCommon StockSEC:0001384101-21-000161:0
4,406 shares@ US$5.983.5% of flowCommon StockSEC:0001384101-21-000155:0
912 shares@ US$52.976.4% of flowCommon StockSEC:0001384101-21-000150:0
4,375 shares@ US$24.6914.2% of flowCommon StockSEC:0001384101-21-000116:0
4,406 shares@ US$5.983.4% of flowCommon StockSEC:0001384101-21-000101:0
912 shares@ US$36.074.2% of flowCommon StockSEC:0001384101-21-000096:0
18 of 18 declarations
About Kennedy Giulia C
Kennedy Giulia C is Chief Scientific & Med Officer at Veracyte, INC. (XNAS). The record shows 18 filings in total, and across the sampled recent filings from 2021-06-04 to 2022-12-08, the sell amount is EUR 52574, with transactions described as Retenue fiscale.
